中财网 中财网股票行情
荣昌生物(688331)财务分析指标    年份：
截止日期2026-06-302026-03-312025-12-312025-09-302025-06-30
营业总收入(万元)585329.3765621.44325105.11171983.30109795.34
营业收入(万元)585329.3765621.44325105.11171983.30109795.34
营业总成本(万元)152163.5169687.88319171.66227206.07154773.56
营业成本(万元)25093.3011695.6541354.0527059.3417501.91
净利润(万元)465432.8632833.8076230.19-50110.77-41955.82
归属于母公司的净利润(万元)466228.3432800.7170964.98-55070.06-44956.87
营业利润(万元)466866.2433017.0372260.59-53726.92-44115.41
利润总额(万元)466287.4732849.3671039.85-55070.06-44956.87
少数股东损益(万元)----------
基本每股收益(元)8.32(元)0.58(元)1.29(元)-1.01(元)-0.83(元)
稀释每股收益(元)8.29(元)0.58(元)1.29(元)-1.01(元)-0.83(元)
非经常性损益(万元)-------545.63--
扣除非经常性损益后净利润(万元)433835.13-3499.106767.55-54524.42-44551.75
总资产(万元)984724.99736519.39724807.23597712.99585035.81
总负债(万元)153317.48343672.93363925.06365704.68349286.75
归属于母公司股东权益合计(万元)831407.51392846.47360882.17232008.31235749.06
股东权益合计(万元)831407.51392846.47360882.17232008.31235749.06
实收资本(股本)(万元)56447.7556447.7556371.0256360.8256360.82
资本公积(万元)695529.52696506.86692379.66692375.71696050.42
未分配利润(万元)109431.71-323995.92-360671.59-487257.18-477143.99
经营活动产生的现金流量净额(万元)421382.291131.805295.1921705.74-24553.93
经营活动现金流入小计(万元)580895.7977060.84271924.14225593.59107758.37
经营活动现金流出小计(万元)159513.4975929.04266628.95203887.84132312.29
投资活动产生的现金流量净额(万元)-202551.222057.98-20564.79-27954.57-11904.98
投资活动现金流入小计(万元)185950.8166455.34216495.91106279.4926165.43
投资活动现金流出小计(万元)388502.0464397.35237060.70134234.0638070.41
筹资活动产生的现金流量净额(万元)-180226.06-8253.2655195.8337096.8788033.61
筹资活动现金流入小计(万元)35909.2219119.03284972.49211727.13197487.55
筹资活动现金流出小计(万元)216135.2827372.29229776.66174630.25109453.94
期末现金及现金等价物余额(万元)152889.46109863.08115459.85106739.01127100.03
最后修改日期2026-08-242026-04-282026-03-282025-11-012025-08-22
↑返回页顶↑

转至荣昌生物（688331）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。